Cite
APA Citation
McNamara, J. J., McColley, S. A., Marigowda, G., Liu, F., Tian, S., Owen, C. A., Stiles, D., Li, C., Waltz, D., Wang, L. T., & Sawicki, G. S. (2019). safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study. Lancet, 7(4), 325–335. http://access.bl.uk/ark:/81055/vdc_100079601737.0x00000d